483sOnline Subscribe

Search By Date Issued

Search By Category

Drug
Device
Clinical

Search By Company/

Clinical Investigator

Search By Region

Search By FDA Investigator

Search By Keyword

Log in to start searching through our library of thousands of 483s, or Subscribe Now to 483sOnline.com to uncover exactly what FDA Inspectors are thinking about. It’s your own personal pre-investigation intelligence tool that identifies exactly what investigators are focusing on so you can be prepared – before they show up.

Antares Pharma, Inc. - Dec. 4, 2018

Issue Date

Dec 04, 2018

Region

Central

Category

Drug
$117.00

Antares Pharma, Inc.

Contact Name

Patrick E. Madsen

Contact Title

Sr. Vice President Operations & General Manager

Form483 Address 1

3905 Annapolis Ln. N.

Form483 Address 2

Ste. 105

Form483 City

Minneapolis

Form483 State

MN

Form483 Postal

55447-5473

Form483 Country

United States

Inspection Range

Nov 27, 2018 - Dec 04, 2018

Pages

2

First Observation

Corrective and preventive action activities and/or results have not been adequately documented.
Investigator(s): Susan M. Matthias